“中国医药行业正进入创新发展期,给阿斯利康在华创新发展带来了更多动力和保障。”阿斯利康中国总经理林骁在第六届跨国公司领导人青岛峰会期间接受经济日报记者采访时说,受中国一系列对外开放政策的鼓舞,阿斯利康正持续深化在华业务布局。今年3月,阿斯利康宣布投资25亿美元在北京建立全球战略研发中心并扩大合作,推动“中国创新”惠及全球。“中国坚持推动高水平对外开放,优化营商环境,推动产业升级,让外商在华发展有了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.